Skip to main content
Fig. 1 | Pediatric Rheumatology

Fig. 1

From: Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review

Fig. 1

Skin rash and pedigrees with mutations in MVK leading to MKD. (A-B) The four limbs with an erythematous maculopapular rash before treatment. (D-E) The four limbs without rash after treatment of tocilizumab. (C, F) The pedigrees with mutations in MVK, which were compound heterozygous mutations (p.Ala148Thr; p.Val49Glu) inherited from mother and father, respectively

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096